longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Aardvark Therapeutics(AARD.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

North American Morning Briefing: Stock Futures Slip Amid Mideast, Inflation Pessimism

MorningStar·05/18/2026 18:19
US
.DJI
+0.69%
US
.IXIC
+1.15%
US
.SPX
+0.78%
MorningStar·05/18/2026 18:19
US
.DJI
+0.69%
US
.IXIC
+1.15%
US
.SPX
+0.78%

FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4

Tip Ranks·05/18/2026 05:06
US
AARD
-2.06%
Tip Ranks·05/18/2026 05:06
US
AARD
-2.06%

Sector Update: Healthcare Stocks Softer Friday Afternoon

Fidelity·05/16/2026 01:51
US
ALMS
+0.72%
US
DXCM
+2.02%
US
SPRY
+5.30%
Fidelity·05/16/2026 01:51
US
ALMS
+0.72%
US
DXCM
+2.02%
US
SPRY
+5.30%

<![CDATA[FDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101]]>

Pharmexec·05/15/2026 21:56
US
AARD
-2.06%
Pharmexec·05/15/2026 21:56
US
AARD
-2.06%

12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga_article·05/15/2026 20:06
US
HCWB
+185.38%
US
PIII
+3.91%
US
AARD
-2.06%
benzinga_article·05/15/2026 20:06
US
HCWB
+185.38%
US
PIII
+3.91%
US
AARD
-2.06%

At a glance: Stocks gapping down premarket

MSN·05/15/2026 19:31
US
AARD
-2.06%
US
CVI
-2.50%
US
IPWR
-1.33%
MSN·05/15/2026 19:31
US
AARD
-2.06%
US
CVI
-2.50%
US
IPWR
-1.33%
© 2026 Longbridge|Disclaimer

Event Tracking

May8
Aardvark Therapeutics released FY2026 Q1 earnings on May 7, 2026 (EST), with actual revenue USD 0 (forecast USD 0) and actual EPS USD -0.9895 (forecast USD -0.9233)
03:00
Mar24
Aardvark Therapeutics released FY2025 Q4 earnings on March 23 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8099 (forecast USD -0.83)
03:00
Aardvark Therapeutics released FY2025 annual earnings on March 23 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.9346 (forecast USD -2.9318)
03:00
Jan12
Aardvark Therapeutics Updates Drug Development Pipeline Presentation
14:36
Dec23
Oppenheimer Rates Aardvark 'Outperform'
12:25
Dec3
BTIG and Raymond James Maintain and Initiate Buy Ratings for Aardvark Therapeutics
15:52

Schedules & Filings

Schedules
Filings
May7
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -21.59 M, EPS -0.9895

Mar23
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -17.6 M, EPS -0.8079

Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -16.32 M, EPS -0.7514

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
5.850
+2,387.24%
+5.615
HCWB
3.000
+183.03%
+1.965
FSHPR
0.1666
+105.43%
+0.086
MWC
9.190
+94.70%
+4.470
GCL
0.7192
+66.60%
+0.287
SLXN
0.4447
+65.32%
+0.171
MTVA
2.750
+46.28%
+0.860
PETZ
1.135
+40.12%
+0.325
EMISR
0.1400
+39.86%
+0.040
CELG.RT
0.1499
+38.80%
+0.042
View More